tiprankstipranks
Trending News
More News >
Anbio Biotechnology Class A (NNNN)
NASDAQ:NNNN
US Market
Advertisement

Anbio Biotechnology Class A (NNNN) Financial Statements

Compare
31 Followers

Anbio Biotechnology Class A Financial Overview

Anbio Biotechnology Class A's market cap is currently $4.90B. The company's EPS TTM is $0.06; its P/E ratio is 561.39; Anbio Biotechnology Class A is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21
Currency in USD

Anbio Biotechnology Class A Earnings and Revenue History

Anbio Biotechnology Class A Debt to Assets

Anbio Biotechnology Class A Cash Flow

Anbio Biotechnology Class A Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis